Abstract:Objectives MicroRNAs, as one of key regulators for post-transcriptional gene control, have shown to be involved in cardiovascular diseases. This study aimed to investigate the roles of miR-378 in regulation of cardiac hypertrophy and cardiac fibrosis stimulated by pressure overload. Methods To construct cardiac remodelling mice models, pressure overload was imposed on the heart of C57B/L6 mice (8 weeks) by constriction of transverse aortic banding (TAC). Chemically modified oligonucleotides miRNA mimics (miR-378-Agomir) and inhibitors (miR-378-Antagomir) treatment started 24 h after TAC by intravenous injections on two consecutive days. Mice were randomly divided into four groups: 1) the TAC group; 2) the TAC-Agomir group; 3) the TAC- Antagomir group; 4) the Sham operation group. Mice after sham or 2 weeks TAC operation were subjected to hemodynamic and echocardiographic measurement. Tissue and serum miR-378 expressions were detected by TaqMan MicroRNA Assay Kit. ANP, BNP, β-MHC, collagen I and collagen III was measured by Real-time PCR. ERK1/2, p-ERK1/2, MMPs and α-SMA expression were analysed by western blotting. Collagen was assessed by immunohistochemistry. Results We found that miR-378 has a high expression pattern in the heart. After two-week acute pressure overload, the TAC group exhibit prominent cardiac hypertrophic responses and decreased expression of miR-378(p < 0.05) comparing with the sham group. In vivo overexpression of miR-378 in TAC-Agomir group markerly inhibited cardiac hypertrophy, accompanied with downregulation of fetal gene ANP, BNP and β-MHC compared to that of TAC group. Howerver, inhibition of endogenous miR-378 by an infusion of an antagomir caused sustained cardiac hypertrophy, associated with a reinduction of fetal gene expression to a less extent. The p-ERK level was also downregulated in TAC-Agomir group and upregulated in TAC- Antagomir group. In part of cardiac fibrosis, we found that the over-expression of miR-378 of TAC-Agomir group reduced the expression of col I, col III, MMP2, MMP9 and α-SMA(p < 0.05) compared to that of TAC group, whereas down regulation of endogenous miR-378 with anti-miRs promoted collagens and MMPs expression. Conclusions These findings reveal orchestrating regulatory roles for miR-378 in pressure-overload induced cardiac remodeling. It suggests that miR-378 not only suppresses cardiac hypertrophy by regulating fetal genes expression and ERK1/2 signaling pathway but also controls fibrosis-related genes expression in the heart.

P71In Vitro and in Vivo Direct Monitoring of Mirna-22 Expression in Isoproterenol-Induced Cardiac Hypertrophy by Bioluminescence Imaging

Cardiac Hypertrophy and Dysfunction Induced by Overexpression of Mir-214 in Vivo

MiroRNA-21 Mediates Myocardial Fibroblasts Paracrine Stimulated by Indoxyl Sulfate in Vitro

Analysis of Microrna Expression Profiles Induced by Yiqifumai Injection in Rats with Chronic Heart Failure

Partial Restoration of Left Ventricular Systolic Function by asPLB Gene Transfer Using Ultrasound-Mediated Microbubble Destruction

Development of a Dual-Luciferase Reporter System for In Vivo Visualization of MicroRNA Biogenesis and Posttranscriptional Regulation

Molecular In Vivo Imaging Using A Noninvasive Cardiac-Specific Mlc-2v Promoter Driven Dual-Gene Recombinant Lentivirus Monitoring System

Abstract 19722: Cardiac Deletion of miRNA-17-92 Cluster Augments Acute Myocardial Ischemia-Reperfusion Injury

MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress.

e0205 MicroRNA regulation of cardiomyocyte lineages from bone marrowderived mesenchymal stem cells

MiR‐218 Regulated Cardiomyocyte Differentiation and Migration in Mouse Embryonic Stem Cells by Targeting PDGFRα

GW24-e2270 MicroRNA-378 Plays Regulatory Roles in Pressure Overload-induced Cardiac Remodelling

MicroRNA miR-27a-3p accelerates cardiac hypertrophy by targeting neuro-oncological ventral antigen 1

Harnessing PUF-Based Reporters for Noninvasive Imaging of the MicroRNA Dynamics in Differentiation

Overexpression of Microrna-99A Attenuates Heart Remodelling and Improves Cardiac Performance after Myocardial Infarction.

Cardiac Hypertrophy is Positively Regulated by MicroRNA-24 in Rats

Cardiac Hypertrophy Is Positively Regulated by MicroRNA miR-23a

Role Of Mir-24 In Myocardial Fibrosis Induced By Angiotensin Ii

In Vivo Imaging of Mlc2v-Luciferase, a Cardiac-Specific Reporter Gene Expression in Mice1

E0051 Mir214 is Upregulated During Ventricular Remodelling Post MI

Overexpression of Microrna-99a Attenuates Cardiac Hypertrophy